POP-HT Trial

  • Research type

    Research Study

  • Full title

    Physician Optimised Post-partum Hypertension Treatment (POP-HT) trial

  • IRAS ID

    273353

  • Contact name

    Paul Leeson

  • Contact email

    Paul.Leeson@cardiov.ox.ac.uk

  • Sponsor organisation

    University of Oxford

  • ISRCTN Number

    ISRCTN00000000

  • Clinicaltrials.gov Identifier

    NCT00000000

  • Duration of Study in the UK

    11 years, 0 months, 0 days

  • Research summary

    We have shown in a pilot randomised controlled study [SNAP-HT; REC 14/SC/1316] that blood pressure self-management during the post-partum period after hypertensive pregnancies, results in lower blood pressure after six months; even when medication has been stopped. We now want to assess whether this blood pressure reduction can be reproduced in a larger, randomised, single-blinded study and whether the blood pressure lowering has additional benefits in terms of other cardiovascular and cerebrovascular changes known to occur in women who have had a hypertensive pregnancy. We therefore plan to run a trial of self-management in the post-partum period, using updated Blue-tooth® enabled blood pressure monitoring coupled to physician-assisted dose titration to further advance the self-management aspect of the intervention. The physicians will be specialist clinicians who form part of the research team. We will measure additional structural and functional end organ differences, using magnetic resonance imaging of the brain and heart as well as echocardiography and retinal imaging. This will provide insight into the impact of post-partum blood pressure control on the maternal cardiovascular system and how this associates with blood pressure changes. Together, these studies will help refine future intervention strategies in this cohort of patients.

    We have consulted the MHRA (MHRA Ref: E/2019/0717) regarding the planned use of 'app' based tele-monitoring and they are satisfied the app is not classed as a medical device (see appendix for e-mail correspondence between MHRA and the research team) and that normal REC and HRA approval should be sought.

  • REC name

    London - Surrey Research Ethics Committee

  • REC reference

    19/LO/1901

  • Date of REC Opinion

    17 Dec 2019

  • REC opinion

    Favourable Opinion